We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search

Refine your search

Content type
Tags
Author
Jurisdiction

10 results found

Article

Foley & Lardner LLP | USA | 12 Jul 2016

The PRICED Act Would Expedite Biosimilar Market Entry

Although the 12-year exclusivity period for original biologic products was a heavily negotiated provision of the Biologics Price Competition and

Article

Foley & Lardner LLP | USA | 12 Jul 2016

The PRICED Act Would Expedite Biosimilar Market Entry

Although the 12-year exclusivity period for original biologic products was a heavily negotiated provision of the Biologics Price Competition and

Article

Foley & Lardner LLP | USA | 5 Jul 2016

Senate Judiciary Introduces CREATES Act To Expedite Access To Affordable Drugs

Following months of public outcry and Congressional probes into significant drug price increases, the Senate Judiciary Committee introduced

Article

Foley & Lardner LLP | USA | 24 Oct 2011

Employers should take a hard look at arbitration

As evidenced by some recent federal court decisions, employers should be carefully considering the benefits of implementing mandatory arbitration provisions, which include waivers of the right to bring a class action, for all employment-related claims.

Article

Foley & Lardner LLP | USA | 18 Apr 2011

Comprehensive medical malpractice reforms advance in House and Senate committees

Last week, several proposals providing additional medical malpractice protection for physicians, hospitals, and medical schools, as well as proposals requiring out-of-state physicians to obtain expert witness certificates in order to testify in medical malpractice actions, advanced in the House and Senate.

Article

Foley & Lardner LLP | USA | 18 Apr 2011

Legislative committees consider constitutional amendments to address the “recapture rule” and lower the non-homestead assessment cap

On Tuesday, the Senate Judiciary Committee approved Senate Joint Resolution 658 by Sen. Mike Fasano.

Article

Foley & Lardner LLP | USA | 21 Dec 2009

Antitrust issues in generic drug settlements: recent developments and considerations in where to draw a line

In the next few months, there will be new legislation (or, failing that, continued antitrust agency enforcement efforts) to restrict the use of litigation settlement agreements to resolve disputes between pharmaceutical industry IP rights holders and generic drug companies.

Article

Foley & Lardner LLP | USA | 9 Oct 2009

The Obama Administration weighs in on patent reform legislation: will the logjam break?

On October 5, 2009, Secretary of Commerce Gary Locke sent a letter to Sen. Patrick Leahy (D-Vt.) and Sen. Jeff Sessions (R-Ala.), the chairman and ranking member of the Senate Judiciary Committee, expressing the Obama Administration's views on S. 515, the Senate version of the patent reform legislation, as reported from the committee.

Article

Foley & Lardner LLP | USA | 5 Oct 2009

Senate President revises committee membership

On October 2, 2009, Senate President Jeff Atwater revised the membership of several Senate committees.

Previous page 1 Next page